American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004 Journal Articles

Overview
Research
Identity
Additional Document Info
View All

authors

Winer, EP
Hudis, C
Burstein, HJ
Wolff, AC
Pritchard, KI
Ingle, JN
Chlebowski, RT
Gelber, R
Edge, SB
Gralow, J
Cobleigh, MA
Mamounas, EP
Goldstein, LJ
Whelan, Timothy
Powles, TJ
Bryant, J
Perkins, C
Perotti, J
Braun, S
Langer, AS
Browman, GP
Somerfield, MR

status

published

publication date

January 20, 2005

has subject area

1103 Clinical Sciences (FoR)
1112 Oncology and Carcinogenesis (FoR)
Aged (MeSH)
Aromatase Inhibitors (MeSH)
Biomarkers, Tumor (MeSH)
Breast Neoplasms (MeSH)
Chemotherapy, Adjuvant (MeSH)
Female (MeSH)
Humans (MeSH)
Middle Aged (MeSH)
Neoplasm Recurrence, Local (MeSH)
Oncology & Carcinogenesis (Science Metrix)
Postmenopause (MeSH)
Prognosis (MeSH)
Randomized Controlled Trials as Topic (MeSH)
Receptors, Estrogen (MeSH)
Receptors, Progesterone (MeSH)
Risk Factors (MeSH)

published in

Journal of Clinical Oncology Journal